These FTSE 100 giants are on my best stocks to buy now list

Conor Coyle reckons these blue-chip UK companies could help grow his portfolio if he bought the shares today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

UK stocks appear to be booming in 2021 after a year that saw some of the steepest declines in the history of the index. While the FTSE 100 still trades some way off its pre-pandemic levels of around 7,600p, the UK’s biggest companies have been boosted by the rollout of the vaccine programme in recent months.

I still think there’s plenty of room for growth in FTSE 100 shares as the UK moves tentatively out of lockdown measures this year. Here are two UK firms I would add to my best stocks to buy now list.

GSK

With a market capitalisation of more than £63bn, pharmaceuticals giant GlaxoSmithKline (LSE:GSK) is one of the biggest companies in the FTSE 100.

GSK’s share price has disappointed investors in recent years though, particularly over the last 12 months as the company’s wider vaccine sales suffered and it seemed to fall behind in developing a Covid vaccine. The shares are down 19% in the last year.

Despite this drop, I see an opportunity to buy GSK shares right now. The company is moving its Covid vaccine through the various trial phases, and demand for this is likely to be strong for years, even after the worst of the pandemic is over.

GSK also has one of the most attractive dividend yields on the index, currently sitting at 6.3%. This would provide me with a decent level of income before factoring in share price fluctuations. 

The group has also said it is to separate its biopharma and consumer healthcare businesses this year, which I think will help to streamline operations.

There are still potential downsides for GSK shares right now though. Its joint vaccine venture with Sanofi isn’t expected to be approved until the end of this year, and the company has also announced it will be changing its dividend structure in 2022, with payouts likely to fall. There’s still uncertainty about how the split in its businesses will also affect the share price.

But I see enough upside to buy GSK shares at the moment.

DGE

Times have been tough for Diageo (LSE:DGE) the maker of Guinness and Johnnie Walker. With bars up and down the country (and globally) shut, lockdown restrictions have led to a challenging environment for the hospitality industry.

Despite that, I have been impressed with how the company has been able to cope during the pandemic. The shares have actually grown 12% in the last 12 months, albeit the shares had already been falling by this point last year.

It’s important to note that Diageo is not just a UK-focused company. It operates in more than 180 countries, many of which haven’t been subject to the same strict lockdowns the UK has seen.

While profits were down by 8% compared to the previous year when the company recently reported its half-year results, I don’t think that’s too damaging considering the wholly different environment the company was operating in. While beer sales have been adversely affected, spirits sales have actually increased due to strong off-trade performance.

There are still headwinds for the Diageo share price though. Potential setbacks to vaccine rollouts in key markets such as the US and Europe could dampen the optimism surrounding the reopening of hospitality venues.

Despite the risk, I’d still add Diageo to my best stocks to buy now list.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

conorcoyle owns shares of Diageo. The Motley Fool UK has recommended Diageo and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »